New Parkinson disease studies offer insights into topics such as LRRK2 G2019S transgene activity, preclinical drug development, and neuroprotection in Parkinson disease.
FDA Grants Regenerative Medicine Advanced Therapy Designation to Kyverna's KYV-101 for Refractory Stiff-Person Syndrome
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
Advances in Therapeutic Management for Parkinson Disease and Essential Tremor
Paradigm Shift in Parkinson’s Disease Diagnosis
NeuroVoices: David Shprecher, DO, MSci, FAAN, on Current and Future Directions in Biomarker Testing for Atypical Parkinsonism
New FNIH Initiative Looks to Expedite Parkinson Disease Diagnosis Through Validated Biomarkers